The GH/IGF-I axis in obesity: influence of neuro-endocrine and metabolic factors

scientific article published on 01 June 2000

The GH/IGF-I axis in obesity: influence of neuro-endocrine and metabolic factors is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P356DOI10.1038/SJ.IJO.0801289
P698PubMed publication ID10997620

P2093author name stringE Ghigo
S Grottoli
M Maccario
R Rossetto
E Arvat
M Procopio
C Gauna
S E Oleandri
P921main subjectobesityQ12174
P304page(s)S96-9
P577publication date2000-06-01
P1476titleThe GH/IGF-I axis in obesity: influence of neuro-endocrine and metabolic factors
P478volume24 Suppl 2

Reverse relations

cites work (P2860)
Q81052208Acute ghrelin response to intravenous dexamethasone administration in idiopathic short stature or isolated idiopathic growth hormone-deficient children
Q47828954Circulating ghrelin levels of visceral obese men are not modified by a short-term treatment with very low doses of GH replacement.
Q79162408Correlates of obesity in postmenopausal women with breast cancer: comparison of genetic, demographic, disease-related, life history and dietary factors
Q36240950Does the pituitary somatotrope play a primary role in regulating GH output in metabolic extremes?
Q33910802Dose-dependent relationship between severity of pediatric obesity and blunting of the growth hormone response to exercise
Q74287154Effects of 36 hour fasting on GH/IGF-I axis and metabolic parameters in patients with simple obesity. Comparison with normal subjects and hypopituitary patients with severe GH deficiency
Q35064726Effects of growth hormone administration in human obesity
Q37863057Fibromyalgia and obesity: the hidden link
Q42440958GH release after GHRH plus arginine administration in obese and overweight women with polycystic ovary syndrome.
Q38287322Glucagon administration elicits blunted GH but exaggerated ACTH response in obesity
Q36789077Growth hormone levels in the diagnosis of growth hormone deficiency in adulthood.
Q34381507Growth hormone-releasing hormone combined with arginine or growth hormone secretagogues for the diagnosis of growth hormone deficiency in adults
Q37737002Growth hormone/insulin-like growth factor-I axis in obstructive sleep apnea syndrome: an update.
Q88603348High Fat Diet Dysregulates Hypothalamic-Pituitary Axis Gene Expression Levels which are Differentially Rescued by EPA and DHA Ethyl Esters
Q48293933Hypothalamic growth hormone-releasing hormone (GHRH) cell number is increased in human illness, but is not reduced in Prader-Willi syndrome or obesity
Q91173821Impact of BMI on peak growth hormone responses to provocative tests and therapeutic outcome in children with growth hormone deficiency
Q36946068Insulin and IGF-I inhibit GH synthesis and release in vitro and in vivo by separate mechanisms.
Q90680826Metabolic and Endocrine Consequences of Bariatric Surgery
Q38118168Obesity, growth hormone and exercise
Q58699812Overweight and obese patients with nickel allergy have a worse metabolic profile compared to weight matched non-allergic individuals
Q24301122Plasma levels of acylated ghrelin during an oral glucose tolerance test in obese children
Q42678045Preoperative prediction of growth hormone (GH)/insulin-like growth factor-1 (IGF-1) axis modification and postoperative changes in candidates for bariatric surgery
Q43268918Prevalence of the metabolic syndrome in moderately-severely obese subjects with and without growth hormone deficiency
Q38060718Role of SST, CORT and ghrelin and its receptors at the endocrine pancreas.
Q36115579Synergistic effect of obesity and lipid ingestion in suppressing the growth hormone response to exercise in children
Q83145586The potential role of increased adrenal volume in the pathophysiology of obesity-related type 2 diabetes
Q92923371The role of IGF-1 in obesity, cardiovascular disease, and cancer
Q45921953[Lipid profile and hormonal study in the schoolchildren of the province of Alicante].

Search more.